You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,488,027


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,488,027
Title: Powder inhaler
Abstract:This invention relates to single dose dry powder inhalers in which medicament is stored in a capsule and is released by piercing the capsule wall with polymer-coated steel pins. Methods of preparation of polymer-coated piercing means and their use in releasing the medicament from the capsule are described.
Inventor(s): Moulin; Claude (Sion, CH)
Assignee: Novartis AG (Basel, CH)
Application Number:09/657,967
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,488,027: A Comprehensive Guide

Introduction

United States Patent 6,488,027, titled "Single dose dry powder inhalers," is a significant invention in the field of medical devices, particularly for respiratory care. This patent, granted on December 10, 2002, describes a novel design for single-dose dry powder inhalers. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent 6,488,027 describes a single-dose dry powder inhaler where the medicament is stored in a capsule and released by piercing the capsule with a needle or similar device. This design ensures that each dose is precisely measured and delivered, enhancing the efficacy and safety of the medication[5].

Key Components

The inhaler consists of several key components:

  • Capsule: Contains the dry powder medicament.
  • Needle or Piercing Device: Used to pierce the capsule and release the medicament.
  • Chamber: Where the medicament is held after the capsule is pierced.
  • Mouthpiece: Through which the patient inhales the medicament.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are crucial as they outline what is considered novel and non-obvious about the invention.

  • Claim 1: Describes the overall apparatus of the single-dose dry powder inhaler, including the capsule, piercing device, chamber, and mouthpiece[5].
  • Claim 10: Focuses on the method of using the inhaler, including the steps of piercing the capsule and inhaling the medicament[5].

Dependent Claims

Dependent claims further specify the details of the invention, often narrowing down the scope by adding additional features or limitations.

  • Claim 2: Specifies that the piercing device is a needle[5].
  • Claim 11: Details the material of the capsule, such as gelatin or a similar biocompatible material[5].

Scope of the Patent

Patent Scope Metrics

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. Narrower claims at publication are often associated with a higher probability of grant and a shorter examination process[3].

  • Claim Length: The length of the independent claims in this patent is moderate, indicating a balanced level of specificity and breadth.
  • Claim Count: The patent includes multiple claims, both independent and dependent, which helps in defining the invention comprehensively.

Patent Examination Process

The examination process for this patent would have involved a thorough review to ensure that the claims are novel, non-obvious, and sufficiently described. The USPTO tends to narrow the scope of patent claims during the examination process, which can affect the final granted claims[3].

Patent Landscape

Technology Area

This patent falls under the medical devices category, specifically within the respiratory care segment. The USPTO classifies such patents under specific technology areas, such as those related to instruments and medical devices[4].

Global Trends

In the broader context, the number of patents in medical devices has been increasing, reflecting the growing innovation in healthcare. Electrical and mechanical engineering patents, which include medical devices, made up a significant portion of USPTO patents in recent years[4].

Competitive Landscape

The competitive landscape in respiratory care is dynamic, with multiple companies and inventors developing innovative devices. Patents like 6,488,027 play a crucial role in protecting intellectual property and encouraging further innovation.

Litigation and Enforcement

Claim Construction and Validity

Patent claims can be subject to litigation, particularly regarding claim construction and validity. The Federal Circuit has established that claim construction is a question of law, and claim indefiniteness is also a legal conclusion[2].

  • Example: In cases like Vascular Solutions LLC v. Medtronic, Inc., the court may appoint an independent expert to analyze claim terms and propose constructions, highlighting the complexity and importance of claim interpretation[2].

Public Search and Access

USPTO Resources

The USPTO provides several resources for searching and accessing patent information, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources can be used to find related patents, understand the patent family, and access file histories[1].

Common Citation Document (CCD)

The CCD application consolidates prior art citations from multiple offices, helping in the visualization of search results for the same invention. This tool is particularly useful for understanding the global patent landscape related to a specific invention[1].

Key Takeaways

  • Invention Description: The patent describes a single-dose dry powder inhaler with a capsule and piercing device.
  • Claims Analysis: Independent and dependent claims define the scope and specifics of the invention.
  • Patent Scope: Metrics like claim length and count help in understanding the breadth and specificity of the patent.
  • Patent Landscape: The patent is part of the broader medical devices category, with trends indicating increasing innovation in healthcare.
  • Litigation and Enforcement: Claim construction and validity are critical in patent litigation.

FAQs

What is the main innovation of United States Patent 6,488,027?

The main innovation is the design of a single-dose dry powder inhaler where the medicament is stored in a capsule and released by piercing the capsule.

How do the claims in this patent define its scope?

The claims, both independent and dependent, specify the components and method of using the inhaler, defining what is novel and non-obvious about the invention.

What resources can be used to find related patents?

Resources such as the USPTO's Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) can be used to find related patents.

Why is claim construction important in patent litigation?

Claim construction is crucial as it determines the scope of the patent and can affect the outcome of litigation regarding validity and infringement.

How does the USPTO classify patents in the medical devices category?

The USPTO classifies patents in the medical devices category using the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. CAFC - VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.: https://cafc.uscourts.gov/opinions-orders/24-1398.OPINION.9-16-2024_2384927.pdf
  3. Hoover Institution - Patent Claims and Patent Scope: https://www.hoover.org/sites/default/files/ip2-wp16001-paper.pdf
  4. NCSES - Invention: U.S. and Comparative Global Trends: https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. US Patent 6,488,027: https://patentimages.storage.googleapis.com/45/0a/41/c9be7a1cb9935d/US6488027.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,488,027

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,488,027

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9805102Mar 10, 1998

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.